Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study

Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study

Background: The study aimed to evaluate real-world effectiveness and toxicity data of trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in pretreated patients with metastatic breast cancer (mBC). Patients and methods: A retrospective multicenter review of medical records of patients with...

Full description

Saved in:
Bibliographic Details
Main Authors: E. Fountzilas, S. Karageorgopoulou, G. Karakatsoulis, D. Tryfonopoulos, K. Papazisis, A. Koutras, A. Koumarianou, G. Zafeiri, E. Biziota, A. Nikolaidi, I. Boukovinas, E. Vrana, D. Mauri, E. Aravantinou-Fatorou, E. Razis, E. Vorrias, Z. Saridaki, D. Bafaloukos, A. Christopoulou, A. Boutis, N. Tsoukalas, S. Stamatopoulou, N. Spathas, M. Theochari, F. Zagouri, A. Psyrri, G. Fountzilas, E. Lalla
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:ESMO Real World Data and Digital Oncology
Subjects:
breast cancer
interstitial lung disease
HER2-low
real-world data
sacituzumab govitecan
trastuzumab deruxtecan
Online Access:http://www.sciencedirect.com/science/article/pii/S2949820124000730
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items